22 Dec 2020
Q32 Bio Appoints Experienced Biopharmaceutical Leader Mark Iwicki as Chairman of Board of Directors
Author: admintech | Filed under: Press ReleaseCAMBRIDGE, Mass., Dec. 22, 2020 /PRNewswire/ — Q32 Bio, a biotechnology company developing therapeutics to restore healthy immune regulation, today announced the appointment of industry leader Mark Iwicki as Chairman of its Board of Directors. Mr. Iwicki will succeed Dr. David Grayzel as…